Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Obstetrics/Gynecology (Women’s Health) | Family Medicine
View By:YearCompanyConditionsTherapeutic AreasDrug Names
Monistat 3 (miconazole nitrate)
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Johnson & Johnson
Approval Status: Approved April 1996
Treatment Area: vaginal yeast infections
MONISTAT 3 Combination Pack has been approved as an over the
counter treatment for vaginal yeast infections. MONISTAT 3 is a
three-day, 200 mg treatment. Most vaginal yeast infection
treatments must be taken for four to seven days. It will be
available in a combination pack of three suppositories and a tube
of 2% moconazole nitrate cream for external relief of symptoms.
While the three suppositories are the internal cure, the cream can
be applied for relief of the external irritation and itching
associated with the condition.
Currently, vaginal yeast infections affect more than 13 million
women each year in the United States. Three quarters of all women
will experience at least one vaginal yeast infection during their